Valuation: Bayer AG

Market Cap 47.2B 55.1B 44.16B 40.42B 75.86B 5,272B 76.87B 522B 203B 2,648B 207B 202B 8,759B P/E 2026 *
20.5x
P/E 2027 * 15.4x
Enterprise Value 77.27B 90.21B 72.3B 66.19B 124B 8,631B 126B 854B 333B 4,336B 339B 331B 14,341B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.58x
Free-Float
99.99%
Yield 2026 *
0.33%
Yield 2027 * 1.1%
1 day-1.67%
1 week+0.85%
1 month+1.72%
3 months+22.92%
6 months+1.72%
Current year+34.09%
1 week 11.6
Extreme 11.6
12.2
1 month 11.2
Extreme 11.2
12.6
Current year 8.2
Extreme 8.2
13.7
1 year 6.35
Extreme 6.35
13.7
3 years 4.38
Extreme 4.38
13.7
5 years 4.38
Extreme 4.38
16.8
10 years 4.38
Extreme 4.38
30.86
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 60 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%+0.85% - - 55.1B
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.20%+6.21%+25.81%+78.74% 468B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
Average +0.99%+4.97%+31.49%+53.44% 422.21B
Weighted average by Cap. +1.10%+5.09%+44.26%+72.65%

Financials

2026 *2027 *
Net sales 45.75B 53.41B 42.81B 39.18B 73.54B 5,110B 74.51B 506B 197B 2,567B 201B 196B 8,490B 46.97B 54.83B 43.95B 40.23B 75.5B 5,246B 76.5B 519B 202B 2,635B 206B 201B 8,717B
Net income 2.13B 2.49B 2B 1.83B 3.43B 238B 3.47B 23.57B 9.19B 120B 9.35B 9.14B 396B 2.95B 3.44B 2.76B 2.52B 4.74B 329B 4.8B 32.58B 12.71B 165B 12.92B 12.64B 547B
Net Debt 30.08B 35.11B 28.14B 25.76B 48.35B 3,360B 48.99B 333B 130B 1,688B 132B 129B 5,582B 26.9B 31.4B 25.17B 23.04B 43.24B 3,005B 43.81B 297B 116B 1,509B 118B 115B 4,992B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
26-08-21 €11.80 -1.67% 0
26-08-20 €12.00 +0.84% 0
26-08-19 €11.90 +2.59% 0
26-08-18 €11.60 -0.85% 0
26-08-17 €11.70 0.00% 27
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.04EUR
Average target price
56.83EUR
Spread / Average Target
+18.30%

Quarterly revenue - Rate of surprise